Fundraising Fox
Asclepii
Founded 2022 · 13 employees on LinkedIn · 3 known investors
Find your way into Asclepii
Sign up to see every warm intro you have to Asclepii
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Asclepii team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Asclepii makes Poseidon, an FDA-cleared nanosilver hydrogel wound dressing that maintains a moist wound environment and blocks microbes for topical wound management. It is used by clinicians such as podiatrists and nurses for chronic and everyday wound care.
Founders & leadership
Asclepii was founded in 2022 by Franco Kraiselburd.
FK
Franco KraiselburdFounder & CEOFranco Kraiselburd is a biomedical engineer who worked as a researcher at the Faculty of Medicine of the University of São Paulo and at the Skeletal Research Center studying mesenchymal stem cells and cancer. He is founder and CEO of Asclepii, which develops biomaterial scaffolds and wound care products.
Investors · 3
Funding
SEC filings, press & company announcements- Undisclosed amountSeed roundApr 2025
Zentynel Frontier Investments (lead), Capital Factory
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Asclepii do?
- Asclepii makes Poseidon, an FDA-cleared nanosilver hydrogel wound dressing that maintains a moist wound environment and blocks microbes for topical wound management. It is used by clinicians such as podiatrists and nurses for chronic and everyday wound care.
- Who founded Asclepii?
- Asclepii was founded by Franco Kraiselburd in 2022.
- Who are Asclepii's investors?
- Asclepii's investors include JumpStart Equity, Zentynel Frontier Investments, Capital Factory.